CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.59
-0.06 (-9.42%)
Financial Highlights (FY 2026)
Revenue
89.85M
Net Income
-72,144,543
Gross Margin
99.5%
Profit Margin
-80.3%
Rev Growth
-2.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 89.85M 92.07M 3.13M 3.55M
Gross Profit 89.42M 91.63M 1.30M 1.47M
Operating Income -54,360,668 -50,132,801 -147,597 -160,008
Net Income -72,144,543 -66,533,547 -134,676 -196,009
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Rev Growth -2.4% -2.4% +0.4% +3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.19M 1.49M
Total Equity — — 5.82M 5.64M
D/E Ratio — — 0.21 0.27
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -52,752,640 -51,352,605 -218,349 -232,431
Free Cash Flow — — -122,296 -194,300